Cost Effectiveness of Immunization: Asking the Right Questions

The Vaccine Book

Volumn , Issue , 2003, Pages 23-36

  Levine, Ruth E ^a  

^a CENTER FOR GLOBAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0842323470     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012107258-2/50004-4     Document Type: Chapter

References (39)

1. World Bank Investing in Health: World Development Report 1993, Oxford University Press, Oxford, UK.
2. Murray C.J.L., Evans D.B., Acharya A., Baltussen R.M.P.M. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ. 2000, 9:235-251.
3. Jefferson T.O., Demicheli V. Elementary Economic Evaluation in Health Care 1996, BMJ Books, London.
4. Drummond M.F., O'Brien B., Stoddart G.L., Torrance G.W. Methods for Economic Evaluation of Health Care Programmes 2001, Oxford University Press, New York. 2nd ed.
5. Kobelt G. Health Economics: An Introduction to Economic Evaluation 1996, Office of Health Economics, London.
6. Valuing Healthcare: Costs, Benefits and Effectiveness of Pharmaceutical and Other Medical Technologies 1996, Cambridge University Press, Cambridge, UK. F. Sloan (Ed.).
7. Gold M.R., Siegel E.S., Russell L.B., Weinstein M.C. Cost-Effectiveness in Health and Medicine 1996, Oxford University Press, New York.
8. Cutting W.A.M. Cost-benefit evaluations of vaccination programmes. Lancet 1980, 20:634-635.
9. Demicheli V., Jefferson T. Economic aspects of vaccination. Vaccine 1996, 14:941-944.
10. Van Damme P., Beutels R. Economic evaluation of vaccination. Pharmacoeconomics 1996, 9(Suppl. 3):8-15.
11. Willems J.S., Sanders C.R. Cost-effectiveness and cost-benefit analyses of vaccines. J. Infect. Dis. 1981, 144:486-493.
12. Creese A.L., Henderson R.H. Cost-benefit analysis and immunization programmes in developing countries. Bull. WHO 1980, 58:491-497.
13. Creese A.L., Sriyabbaya N., Casabal G., Wiseso G. Cost-effectiveness appraisal of immunization programmes. Bull. WHO 1982, 60:621-632.
14. Haaga J. Cost-effectiveness and cost-benefit analyses of immunization programmes in developing countries. Advances in International Maternal and Child Health 1986, Vol. VI. Clarendon Press, Oxford, UK. D.B. Jelliffe, E.F.P. Jelliffe (Eds.).
15. Hinman A.R. Economic aspects of vaccines and immunizations. C.R. Acad. Sci. III 1999, 322:989-994.
16. Edmunds W.J., Gay N.J., Gay J.R., Brisson M. The Cost-Effectiveness of Haemophilus influenzae Type b (Hib), Hepatitis B Virus (HBV) and Measles Vaccination in Developing Countries. Preliminary report to WHO 1999.
17. Walker D., Khan S., Akramuzzaman S., Khan M., Rushby J.F., Cutts F. Cost-effectiveness analysis of measles control in Dhaka, Bangladesh 1999, (ref.no. HQ/98/4544190116328), WHO.
18. Jha P., Bangoura O., Ranson K. The cost-effectiveness of forty health interventions in Guinea. Health Pol. Plan. 1998, 13:249-262.
19. Jamison D.T., Mosley W.H.O., Measham A.R., Bobadilla J.L. Disease Control Priorities in Developing Countries 1993, Oxford University Press, Oxford, UK.
20. WHO Expanded programme on immunization: Economic Appraisal, Thailand. Weekly Epidemiol. Record 1980, 55:289-296.
21. Phonboon K., Shepard D.S., Ramaboot S., Kunasol P., Preuksaraj S. The Thai expanded programme on immunization: Role of immunization sessions and their cost-effectiveness. Bull. WHO 1989, 67:181-188.
22. Barnum H.N., Tarantola D., Setaidy I.F. Cost-effectiveness of an immunization programme in Indonesia. Bull. WHO 1980, 58:499-503.
23. Robertson R.L., Qualls N. Cost-effectiveness of immunization in the Gambia. J. Tropical Med. Hygiene 1985, 88:343-351.
24. Shepard D.S., Sanoh L., Coffi E. Cost-effectiveness of the expanded programme on immunization in the Ivory Coast: A preliminary assessment. Soc. Sci. Med. 1986, 22:369-377.
25. Creese A.L., Dominguez-Uga M.A. Cost-effectiveness of immunization programs in Colombia. Bull. PAHO 1987, 21:377-394.
26. Creese A.L. Cost-effectiveness of alternative strategies for poliomyelitis immunization in Brazil. Rev. Infect. Dis. 1984, 6:S404-S407.
27. Dominguez-Uga M.A. Economic analysis of the vaccination strategies adopted in Brazil in 1982. Bull. PAHO 1988, 22:250-268.
28. Disha A., Khan M.M. Economic evaluation of hepatitis B vaccination in Bangladesh. Inter-Divisional Scientific Forum, ICDDR,B 1998.
29. Hussey G.D., Lasser M.L., Reekie W.D. The costs and benefits of a vaccination programme for Haemophilus influenzae type B disease. S. African Med. J. 1995, 85.
30. Beutels P. Economic evaluations of hepatitis B immunization: A global review of recent studies (1994-2000). Health Econ. 2001, 10:751-774.
31. Miller M. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia. Ped. Infect. Dis. J. 1998, 17:S152-S159.
32. Miller M., McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b, streptococcus pneumonia-conjugate and rotavirus vaccines in national immunization schedules. Health Econ. 2000, 9:19-35.
33. Granata A.V., Hillman A.L. Competing practice guidelines: Using cost-effectiveness analysis to make optimal decisions. Ann. Intern. Med. 1998, 128:56-63.
34. Robinson R. Limits to rationality: Economics, economists and priority setting. Health Pol. 1999, 49:13-26.
35. England S., Loevinsohn B., Melgaard B., Kou U., Jha P. The evidence base for interventions to reduce mortality from vaccine-preventable diseases in low and middle-income countries. CMH Working Paper Ser. WG5 2001, 10.
36. Fenwick E., Claxton K., Sculpher M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ. 2001, 10:779-787.
37. Baltussen R.M.P.M., Hutubessy R.C.W., Evans D.B., Murray C.J.L. Uncertainty in cost-effectiveness analysis: Probabilistic uncertainty analysis and stochastic league tables. WHO GPE Discuss. Paper Ser. 2001, 34.
38. Briggs A.H. A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ. 1999, 8:257-261.
39. Briggs A.H., Gray A.M. Handling uncertainty in economic evaluation of healthcare interventions. Br. Med. J. 1999, 319:635-638.